 |
 |

Monoclonal Gammopathy in Sézary SyndromeReport of Three Cases and Review of the Literature
Pierre Y. Venencie, MD;
R. K. Winkelmann, MD, PhD;
A. Puissant, MD;
Robert A. Kyle, MD
Arch Dermatol. 1984;120(5):605-608.
Abstract
Three patients with Sézary syndrome had monoclonal gammopathy: two had gammopathy of unknown significance and one had myeloma. The frequency of the association of Sézary syndrome and monoclonal gammopathy seems to be lower than previously suggested. However, it does emphasize that the presence of T-cell cutaneous disease does not preclude B-cell clonal proliferation.
(Arch Dermatol 1984;120:605-608)
Author Affiliations
From the Department of Dermatology (Dr Winkelmann) and the Division of Hematology and Internal Medicine (Dr Kyle), Mayo Clinic and Mayo Foundation, Rochester, Minn, and the Clinique Dermatologique, Hôpital St Louis, Paris (Drs Venencie and Puissant). Dr Venencie is presently a visiting clinician in the Department of Dermatology, Mayo Clinic and Mayo Foundation.
Footnotes
Accepted for publication Oct 13, 1983.
Reprints not available.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients
Bida et al.
Mayo Clin Proc. 2009;84:685-693.
ABSTRACT
| FULL TEXT
|